Evidence map›Paper›PMID 31605211›Full record

ReviewPediatric nephrology (Berlin, Germany)2020

Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists.

Heidi J Murphy, Brady Thomas, Brynna Van Wyk, Sarah B Tierney, David T Selewski, Jennifer G Jetton

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Heidi J MurphyDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
Brady ThomasStead Family Department of Pediatrics, Division of Neonatology, University of Iowa, Iowa City, IA, USA.
Brynna Van WykStead Family Department of Pediatrics, Division of Nephrology, Dialysis, and Transplantation, University of Iowa, 200 Hawkins Drive, 2027 BT, Iowa City, IA, 52241, USA.
Sarah B TierneyDepartment of Pharmaceutical Care, University of Iowa Stead Family Children's Hospital, Iowa City, IA, USA.
David T SelewskiDepartment of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
Jennifer G JettonStead Family Department of Pediatrics, Division of Nephrology, Dialysis, and Transplantation, University of Iowa, 200 Hawkins Drive, 2027 BT, Iowa City, IA, 52241, USA. jennifer-jetton@uiowa.edu.ORCID 0000-0003-0962-3880
University of Iowa · USMedical University of South Carolina · USUniversity of Iowa Stead Family Children’s Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal acute kidney injury (AKI) is common. Critically ill neonates are at risk for AKI for many reasons including the severity of their underlying illnesses, prematurity, and nephrotoxic medications. In this educational review, we highlight four clinical scenarios in which both the illness itself and the medications indicated for their treatment are risk factors for AKI: sepsis, perinatal asphyxia, patent ductus arteriosus, and necrotizing enterocolitis. We review the available evidence regarding medications commonly used in the neonatal period with known nephrotoxic potential, including gentamicin, acyclovir, indomethacin, vancomycin, piperacillin-tazobactam, and amphotericin. We aim to illustrate the complexity of decision-making involved for both neonatologists and pediatric nephrologists when managing infants with these conditions and advocate for ongoing multidisciplinary collaboration in the development of better AKI surveillance protocols and AKI mitigation strategies to improve care for these vulnerable patients.

Indexed as

Acute Kidney InjuryAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalFemaleHumansInfantInfant, NewbornInfant, PrematureInfant, Premature, DiseasesIntensive Care Units, NeonatalMaleNeonatologyNephrologyRisk FactorsAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalAntibioticsHypoxic ischemic encephalopathyNecrotizing enterocolitisNeonatal sepsisNonsteroidal anti-inflammatory drugsPatent ductus arteriosus

Identifiers

PMID31605211
OpenAlexW2979544786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.